Wells Fargo raised the firm’s price target on Stryker (SYK) to $405 from $381 and keeps an Overweight rating on the shares. The firm notes Q3 sales and EPS beat expectations, and 2024 guidance was narrowed from 9.0%-10.0% to 9.5%-10.0% organic sales growth and EPS was also narrowed from $11.90-$12.10 to $12.00-$12.10.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.